TY - JOUR
T1 - The patterns and dynamics of genomic instability in metastatic pancreatic cancer
AU - Campbell, Peter J.
AU - Yachida, Shinichi
AU - Mudie, Laura J.
AU - Stephens, Philip J.
AU - Pleasance, Erin D.
AU - Stebbings, Lucy A.
AU - Morsberger, Laura A.
AU - Latimer, Calli
AU - McLaren, Stuart
AU - Lin, Meng Lay
AU - McBride, David J.
AU - Varela, Ignacio
AU - Nik-Zainal, Serena A.
AU - Leroy, Catherine
AU - Jia, Mingming
AU - Menzies, Andrew
AU - Butler, Adam P.
AU - Teague, Jon W.
AU - Griffin, Constance A.
AU - Burton, John
AU - Swerdlow, Harold
AU - Quail, Michael A.
AU - Stratton, Michael R.
AU - Iacobuzio-Donahue, Christine
AU - Futreal, P. Andrew
N1 - Funding Information:
Acknowledgements This work was supported by the Wellcome Trust (grant reference 077012/Z/05/Z). P.J.C. is funded through a Wellcome Trust Senior Clinical Research Fellowship (grant reference WT088340MA). S.Y. has support from the Uehara memorial foundation. We would also like to acknowledge the financial support of the Skip Viragh Foundation and the Michael Rolphe Foundation for the autopsy programme, and funding from the National Institutes of Health (grants CA106610 and CA140599). I.V. is supported by a fellowship from The International Human Frontier Science Program Organization. We would like to thank U. McDermott for discussions and a critical reading of the manuscript.
PY - 2010/10/28
Y1 - 2010/10/28
N2 - Pancreatic cancer is an aggressive malignancy with a five-year mortality of 97-98%, usually due to widespread metastatic disease. Previous studies indicate that this disease has a complex genomic landscape, with frequent copy number changes and point mutations, but genomic rearrangements have not been characterized in detail. Despite the clinical importance of metastasis, there remain fundamental questions about the clonal structures of metastatic tumours, including phylogenetic relationships among metastases, the scale of ongoing parallel evolution in metastatic and primary sites, and how the tumour disseminates. Here we harness advances in DNA sequencing to annotate genomic rearrangements in 13 patients with pancreatic cancer and explore clonal relationships among metastases. We find that pancreatic cancer acquires rearrangements indicative of telomere dysfunction and abnormal cell-cycle control, namely dysregulated G1-to-S-phase transition with intact G2-M checkpoint. These initiate amplification of cancer genes and occur predominantly in early cancer development rather than the later stages of the disease. Genomic instability frequently persists after cancer dissemination, resulting in ongoing, parallel and even convergent evolution among different metastases. We find evidence that there is genetic heterogeneity among metastasis-initiating cells, that seeding metastasis may require driver mutations beyond those required for primary tumours, and that phylogenetic trees across metastases show organ-specific branches. These data attest to the richness of genetic variation in cancer, brought about by the tandem forces of genomic instability and evolutionary selection.
AB - Pancreatic cancer is an aggressive malignancy with a five-year mortality of 97-98%, usually due to widespread metastatic disease. Previous studies indicate that this disease has a complex genomic landscape, with frequent copy number changes and point mutations, but genomic rearrangements have not been characterized in detail. Despite the clinical importance of metastasis, there remain fundamental questions about the clonal structures of metastatic tumours, including phylogenetic relationships among metastases, the scale of ongoing parallel evolution in metastatic and primary sites, and how the tumour disseminates. Here we harness advances in DNA sequencing to annotate genomic rearrangements in 13 patients with pancreatic cancer and explore clonal relationships among metastases. We find that pancreatic cancer acquires rearrangements indicative of telomere dysfunction and abnormal cell-cycle control, namely dysregulated G1-to-S-phase transition with intact G2-M checkpoint. These initiate amplification of cancer genes and occur predominantly in early cancer development rather than the later stages of the disease. Genomic instability frequently persists after cancer dissemination, resulting in ongoing, parallel and even convergent evolution among different metastases. We find evidence that there is genetic heterogeneity among metastasis-initiating cells, that seeding metastasis may require driver mutations beyond those required for primary tumours, and that phylogenetic trees across metastases show organ-specific branches. These data attest to the richness of genetic variation in cancer, brought about by the tandem forces of genomic instability and evolutionary selection.
UR - http://www.scopus.com/inward/record.url?scp=78049380554&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78049380554&partnerID=8YFLogxK
U2 - 10.1038/nature09460
DO - 10.1038/nature09460
M3 - Article
C2 - 20981101
AN - SCOPUS:78049380554
VL - 467
SP - 1109
EP - 1113
JO - Nature
JF - Nature
SN - 0028-0836
IS - 7319
ER -